{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:56:57Z","timestamp":1781744217239,"version":"3.54.5"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172649"],"award-info":[{"award-number":["82172649"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474061"],"award-info":[{"award-number":["82474061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013806","name":"Shenyang Pharmaceutical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024NSFSC0627"],"award-info":[{"award-number":["2024NSFSC0627"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijbiomac.2025.148014","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T15:19:30Z","timestamp":1759245570000},"page":"148014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P3","title":["Unravelling the oncogenic role of eukaryotic elongation factor 2 kinase: A revisited review from underlying mechanisms to targeted therapy"],"prefix":"10.1016","volume":"330","author":[{"given":"Lingjuan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minru","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junning","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ijbiomac.2025.148014_bb0005","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.1073\/pnas.82.23.7939","article-title":"Identification of calmodulin-dependent protein kinase III and its major Mr 100,000 substrate in mammalian tissues","volume":"82","author":"Nairn","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.148014_bb0010","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1021\/acs.jmedchem.0c02218","article-title":"Inhibiting eukaryotic elongation factor 2 kinase: an update on pharmacological small-molecule compounds in cancer","volume":"64","author":"Zhu","year":"2021","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148014_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9120162","article-title":"Eukaryotic elongation factor 2 kinase (eEF2K) in cancer","volume":"9","author":"Wang","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148014_bb0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.tibs.2023.11.004","article-title":"Revealing eEF-2 kinase: recent structural insights into function","volume":"49","author":"Piserchio","year":"2024","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/aps.2015.123","article-title":"Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases","volume":"37","author":"Liu","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031095","article-title":"eEF2K inhibitor design: the progression of exemplary structure-based drug design","volume":"28","author":"Klupt","year":"2023","journal-title":"Molecules"},{"issue":"6178","key":"10.1016\/j.ijbiomac.2025.148014_bb0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/334170a0","article-title":"Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation","volume":"334","author":"Ryazanov","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbior.2014.04.003","article-title":"Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles","volume":"55","author":"Kenney","year":"2014","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.727863","article-title":"Insights into the pathologic roles and regulation of eukaryotic elongation factor-2 kinase","volume":"8","author":"Ballard","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41419-025-07803-w","article-title":"eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment","volume":"16","author":"Karakas","year":"2025","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148014_bb0055","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/ijc.32560","article-title":"Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K\/Akt and STAT3","volume":"146","author":"Zhou","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.lungcan.2018.07.027","article-title":"Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer","volume":"124","author":"Bircan","year":"2018","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148014_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.722","article-title":"EEF2K silencing inhibits tumour progression through repressing SPP1 and synergises with BET inhibitors in melanoma","volume":"12","author":"Deng","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148014_bb0070","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1021\/acs.jmedchem.0c01180","article-title":"Small-molecule drug discovery in triple negative breast cancer: current situation and future directions","volume":"64","author":"Liao","year":"2021","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.radonc.2017.04.001","article-title":"eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma","volume":"124","author":"Zhu","year":"2017","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cellsig.2016.10.006","article-title":"Discovery of new substrates of the elongation factor-2 kinase suggests a broader role in the cellular nutrient response","volume":"29","author":"Lazarus","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0085","article-title":"Identification of a novel substrate for eEF2K and the AURKA-SOX8 as the related pathway in TNBC","volume":"e2412985","author":"Wan","year":"2025","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148014_bb0090","article-title":"Progress in the development of eukaryotic elongation factor 2 kinase (eEF2K) natural product and synthetic small molecule inhibitors for cancer chemotherapy","volume":"22","author":"Bin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148014_bb0095","article-title":"Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target","volume":"98","author":"Didem","year":"2020","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"0","key":"10.1016\/j.ijbiomac.2025.148014_bb0100","article-title":"What is the impact of eukaryotic elongation factor 2 kinase on cancer: a systematic review","volume":"857","author":"Shumin","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148014_bb0105","article-title":"Targeting eukaryotic elongation factor 2 kinase (eEF2K) with small-molecule inhibitors for cancer therapy","volume":"29","author":"Huiping","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0110","article-title":"eEF2K inhibitor design: the progression of exemplary structure-based drug design","volume":"28","author":"Kody A","year":"2023","journal-title":"Molecules"},{"issue":"0","key":"10.1016\/j.ijbiomac.2025.148014_bb0115","article-title":"Insights into the pathologic roles and regulation of eukaryotic elongation factor-2 kinase","volume":"8","author":"Darby J","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.148014_bb0120","article-title":"Inhibiting eukaryotic elongation factor 2 kinase: an update on pharmacological small-molecule compounds in cancer","volume":"64","author":"Shiou","year":"2021","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148014_bb0125","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.21037\/tau-21-18","article-title":"Eef2k is not required for fertility in male mice","volume":"10","author":"Feng","year":"2021","journal-title":"Transl. Androl. Urol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148014_bb0130","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/emboj.2008.39","article-title":"cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner","volume":"27","author":"Smith","year":"2008","journal-title":"EMBO J."},{"issue":"Pt 3","key":"10.1016\/j.ijbiomac.2025.148014_bb0135","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj3530621","article-title":"Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-dependent protein kinase induces Ca2+\/calmodulin-independent activity","volume":"353","author":"Diggle","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-662-09889-9_4","article-title":"Elongation factor-2 phosphorylation and the regulation of protein synthesis by calcium","volume":"27","author":"Nairn","year":"2001","journal-title":"Prog. Mol. Subcell. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.bjc.6690012","article-title":"Activity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancer","volume":"79","author":"Parmer","year":"1999","journal-title":"Br. J. Cancer"},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.148014_bb0150","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1002\/pmic.200600365","article-title":"Identification of G2\/M targets for the MAP kinase pathway by functional proteomics","volume":"6","author":"Roberts","year":"2006","journal-title":"Proteomics"},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.148014_bb0155","first-page":"6894","article-title":"Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines","volume":"63","author":"Arora","year":"2003","journal-title":"Cancer Res."},{"issue":"5\u20136","key":"10.1016\/j.ijbiomac.2025.148014_bb0160","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.molonc.2009.05.003","article-title":"The role of protein synthesis in cell cycling and cancer","volume":"3","author":"White-Gilbertson","year":"2009","journal-title":"Mol. Oncol."},{"issue":"7535","key":"10.1016\/j.ijbiomac.2025.148014_bb0165","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature13896","article-title":"mTORC1-mediated translational elongation limits intestinal tumour initiation and growth","volume":"517","author":"Faller","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13045-022-01260-0","article-title":"Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies","volume":"15","author":"Liao","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148014_bb0175","article-title":"Targeting programmed cell death using small-molecule compounds to improve potential cancer therapy","volume":"36","author":"Bowen","year":"2016","journal-title":"Med. Res. Rev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148014_bb0180","article-title":"Targeting autophagy-related protein kinases for potential therapeutic purpose","volume":"10","author":"Honggang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148014_bb0185","article-title":"Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease","volume":"11","author":"Kai","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148014_bb0190","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4161\/auto.22801","article-title":"Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells","volume":"9","author":"Cheng","year":"2013","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148014_bb0195","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1158\/0008-5472.CAN-10-2889","article-title":"eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206","volume":"71","author":"Cheng","year":"2011","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4161\/auto.5224","article-title":"Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy","volume":"4","author":"Gills","year":"2008","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0205","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4161\/auto.5.3.7762","article-title":"A critical role of eEF-2K in mediating autophagy in response to multiple cellular stresses","volume":"5","author":"Py","year":"2009","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148014_bb0210","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.4161\/auto.29164","article-title":"Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells","volume":"10","author":"Xie","year":"2014","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148014_bb0215","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cellsig.2016.01.005","article-title":"Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy","volume":"28","author":"Moore","year":"2016","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148014_bb0220","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1172\/JCI28833","article-title":"Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma","volume":"117","author":"Amaravadi","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148014_bb0225","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1158\/0008-5472.CAN-08-2872","article-title":"Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy","volume":"69","author":"Wu","year":"2009","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148014_bb0230","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1158\/0008-5472.CAN-05-1554","article-title":"Elongation factor-2 kinase regulates autophagy in human glioblastoma cells","volume":"66","author":"Wu","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-024-09966-2","article-title":"eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3beta and improving autophagy dysfunction","volume":"41","author":"Guan","year":"2024","journal-title":"Cell Biol. Toxicol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148014_bb0240","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12192-014-0545-0","article-title":"Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cells","volume":"20","author":"Zhu","year":"2015","journal-title":"Cell Stress Chaperones"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148014_bb0245","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1128\/MCB.26.10.3955-3965.2006","article-title":"Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells","volume":"26","author":"Connolly","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.148014_bb0250","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.2174\/1871520622666220117123213","article-title":"miRNA-193b-5p suppresses pancreatic cancer cell proliferation, invasion, epithelial mesenchymal transition, and tumor growth by inhibiting eEF2K","volume":"22","author":"Gurbuz","year":"2022","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148014_bb0255","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ccr.2013.05.012","article-title":"Adaptation to starvation: translating a matter of life or death","volume":"23","author":"Manning","year":"2013","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148014_bb0260","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/MCB.00012-15","article-title":"Molecular mechanism for the control of eukaryotic elongation factor 2 kinase by pH: role in cancer cell survival","volume":"35","author":"Xie","year":"2015","journal-title":"Mol. Cell. Biol."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2025.148014_bb0265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/bj3120163","article-title":"A hierarchy of ATP-consuming processes in mammalian cells","volume":"312","author":"Buttgereit","year":"1995","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148014_bb0270","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10456-022-09849-2","article-title":"The rising impact of angiogenesis research","volume":"25","author":"Griffioen","year":"2022","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0275","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/13880209.2023.2204879","article-title":"Sodium tanshinone IIA sulphate inhibits angiogenesis in lung adenocarcinoma via mediation of miR-874\/eEF-2K\/TG2 axis","volume":"61","author":"Wang","year":"2023","journal-title":"Pharm. Biol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148014_bb0280","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1007\/s11064-022-03679-w","article-title":"Eukaryotic extension factor 2 kinase may affect the occurrence and development of glioblastoma through immune cell infiltration","volume":"47","author":"Cen","year":"2022","journal-title":"Neurochem. Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148014_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041171","article-title":"Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer","volume":"7","author":"Tekedereli","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.109938","article-title":"Targeting eukaryotic elongation factor-2 kinase suppresses the growth and peritoneal metastasis of ovarian cancer","volume":"81","author":"Erdogan","year":"2021","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148014_bb0295","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/ijc.31210","article-title":"Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis","volume":"142","author":"Xie","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0300","article-title":"Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Minru","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"49","key":"10.1016\/j.ijbiomac.2025.148014_bb0305","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1038\/onc.2016.166","article-title":"eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis","volume":"35","author":"Cheng","year":"2016","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148014_bb0310","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7150\/ijbs.26077","article-title":"Atg7 inhibits Warburg effect by suppressing PKM2 phosphorylation resulting reduced epithelial-mesenchymal transition","volume":"14","author":"Feng","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148014_bb0315","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00109-020-01917-8","article-title":"Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target","volume":"98","author":"Karakas","year":"2020","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148014_bb0320","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2013.04.055","article-title":"The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation","volume":"153","author":"Leprivier","year":"2013","journal-title":"Cell"},{"issue":"45","key":"10.1016\/j.ijbiomac.2025.148014_bb0325","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1021\/bi026494p","article-title":"Regulation of elongation factor-2 kinase by pH","volume":"41","author":"Dorovkov","year":"2002","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148014_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305035","article-title":"Design and characterization of a novel eEF2K degrader with potent therapeutic efficacy against triple-negative breast cancer","volume":"11","author":"Zhong","year":"2024","journal-title":"Adv. Sci."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.148014_bb0335","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1093\/emboj\/20.16.4370","article-title":"Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase","volume":"20","author":"Wang","year":"2001","journal-title":"EMBO J."},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.148014_bb0340","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1128\/MCB.01035-14","article-title":"Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling","volume":"34","author":"Wang","year":"2014","journal-title":"Mol. Cell. Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148014_bb0345","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.15252\/embr.201642194","article-title":"Pharmacological eEF2K activation promotes cell death and inhibits cancer progression","volume":"17","author":"De Gassart","year":"2016","journal-title":"EMBO Rep."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148014_bb0350","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1038\/s41375-023-02043-3","article-title":"mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia","volume":"37","author":"Malik","year":"2023","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.148014_bb0355","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1093\/emboj\/20.16.4360","article-title":"A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4\/p38delta","volume":"20","author":"Knebel","year":"2001","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148014_bb0360","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","article-title":"TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth","volume":"126","author":"Inoki","year":"2006","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148014_bb0365","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.molcel.2021.01.032","article-title":"PQBP1 promotes translational elongation and regulates hippocampal mGluR-LTD by suppressing eEF2 phosphorylation","volume":"81","author":"Shen","year":"2021","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148014_bb0370","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41419-023-06341-7","article-title":"The aryl hydrocarbon receptor controls mesenchymal stromal cell-mediated immunomodulation via ubiquitination of eukaryotic elongation factor-2 kinase","volume":"14","author":"Lkhagva-Yondon","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0375","doi-asserted-by":"crossref","first-page":"29284","DOI":"10.1038\/s41598-024-78652-4","article-title":"eEF2K as an important kinase associated with cancer survival and prognosis","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148014_bb0380","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-5793(87)80081-9","article-title":"Ca2+\/calmodulin-dependent phosphorylation of elongation factor 2","volume":"214","author":"Ryazanov","year":"1987","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0385","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/BJ20111536","article-title":"Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains","volume":"442","author":"Pigott","year":"2012","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148014_bb0390","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41573-019-0019-2","article-title":"AMP-activated protein kinase: the current landscape for drug development","volume":"18","author":"Steinberg","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0395","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cellsig.2017.05.010","article-title":"Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase","volume":"36","author":"Johanns","year":"2017","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148014_bb0400","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1158\/0008-5472.CAN-20-3044","article-title":"HDAC11 regulates glycolysis through the LKB1\/AMPK signaling pathway to maintain hepatocellular carcinoma stemness","volume":"81","author":"Bi","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0405","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41392-023-01367-x","article-title":"RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0410","first-page":"32","article-title":"Effects of GSK3\u03b2\/eEF2K signaling pathway on pulmonary fibrosis in mice","volume":"38","author":"Qin","year":"2022","journal-title":"Zhongguo ying yong sheng li xue za zhi"},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.148014_bb0415","article-title":"Designing an eEF2K-targeting PROTAC small molecule that induces apoptosis in MDA-MB-231 cells","volume":"204","author":"Liu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2019.12.008","article-title":"Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy","volume":"80","author":"Tewari","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148014_bb0425","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.15252\/emmm.201404402","article-title":"Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K","volume":"6","author":"Liu","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0430","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13045-024-01524-x","article-title":"cAMP-PKA\/EPAC signaling and cancer: the interplay in tumor microenvironment","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148014_bb0435","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1038\/s41418-021-00761-8","article-title":"PKA compartmentalization links cAMP signaling and autophagy","volume":"28","author":"Grisan","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0440","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.29219\/fnr.v65.3602","article-title":"Synergistic antitumor effect of resveratrol and sorafenib on hepatocellular carcinoma through PKA\/AMPK\/eEF2K pathway","volume":"65","author":"Gao","year":"2021","journal-title":"Food Nutr. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148014_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2022.100240","article-title":"eEF2K activity determines synergy to cotreatment of cancer cells with PI3K and MEK inhibitors","volume":"21","author":"Hijazi","year":"2022","journal-title":"Mol. Cell. Proteomics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0450","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0455","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10495-013-0927-2","article-title":"Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells","volume":"19","author":"Ashour","year":"2014","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0460","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-5793(94)80121-5","article-title":"Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine","volume":"338","author":"Gschwendt","year":"1994","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0465","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-4165(00)00061-1","article-title":"Novel compounds, \u20181,3-selenazine derivatives\u2019 as specific inhibitors of eukaryotic elongation factor-2 kinase","volume":"1475","author":"Cho","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148014_bb0470","first-page":"4010","article-title":"Disruption of the EF-2 kinase\/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin","volume":"61","author":"Yang","year":"2001","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0475","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1087057113505204","article-title":"High-throughput screens for eEF-2 kinase","volume":"19","author":"Devkota","year":"2014","journal-title":"J. Biomol. Screen."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148014_bb0480","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/S0968-0896(02)00160-8","article-title":"TX-1123: an antitumor 2-hydroxyarylidene-4-cyclopentene-1,3-dione as a protein tyrosine kinase inhibitor having low mitochondrial toxicity","volume":"10","author":"Hori","year":"2002","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148014_bb0485","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1021\/bi201787p","article-title":"Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact","volume":"51","author":"Devkota","year":"2012","journal-title":"Biochemistry"},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.148014_bb0490","doi-asserted-by":"crossref","first-page":"13355","DOI":"10.1080\/07391102.2019.1592024","article-title":"Structure prediction of eukaryotic elongation factor-2 kinase and identification of the binding mechanisms of its inhibitors: homology modeling, molecular docking, and molecular dynamics simulation","volume":"40","author":"Tatar","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0495","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1021\/acs.jcim.9b01083","article-title":"Design, synthesis, and molecular modeling studies of novel coumarin carboxamide derivatives as eEF-2K inhibitors","volume":"60","author":"Comert Onder","year":"2020","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148014_bb0500","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.bmcl.2010.02.005","article-title":"Inhibition of eEF2-K by thieno[2,3-b]pyridine analogues","volume":"20","author":"Lockman","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"51","key":"10.1016\/j.ijbiomac.2025.148014_bb0505","doi-asserted-by":"crossref","first-page":"43951","DOI":"10.1074\/jbc.M111.301291","article-title":"1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.148014_bb0510","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1016\/j.bmc.2014.06.050","article-title":"Synthesis and biological evaluation of pyrido[2,3-d]pyrimidine-2,4-dione derivatives as eEF-2K inhibitors","volume":"22","author":"Edupuganti","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0515","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1039\/C5MB00848D","article-title":"Integrative bioinformatics and proteomics-based discovery of an eEF2K inhibitor (cefatrizine) with ER stress modulation in breast cancer cells","volume":"12","author":"Yao","year":"2016","journal-title":"Mol. BioSyst."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148014_bb0520","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.apsb.2016.04.002","article-title":"A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors","volume":"6","author":"Xiao","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0525","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ejmech.2017.11.065","article-title":"Design, synthesis and structure-activity relationship of a focused library of \u03b2-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer","volume":"143","author":"Guo","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148014_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104155","article-title":"Targeting eukaryotic elongation factor 2 kinase (eEF2K) with small-molecule inhibitors for cancer therapy","volume":"29","author":"Wang","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148014_bb0535","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/bph.17345","article-title":"Pharmacokinetics and cardioprotective efficacy of intravenous miR-125b* microRNA mimic in a mouse model of acute myocardial infarction","volume":"182","author":"Szabados","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.148014_bb0540","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.omtn.2021.01.016","article-title":"ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer","volume":"23","author":"Gorur","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128759","article-title":"In silico, synthesis and anticancer evaluation of benzamide tryptamine derivatives as novel eEF2K inhibitors","volume":"67","author":"Liu","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"27","key":"10.1016\/j.ijbiomac.2025.148014_bb0550","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo2039","article-title":"Structural basis for the calmodulin-mediated activation of eukaryotic elongation factor 2 kinase","volume":"8","author":"Piserchio","year":"2022","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148014_bb0555","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1039\/D2MD00105E","article-title":"Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy","volume":"13","author":"Comert Onder","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105296","article-title":"Novel inhibitors of eukaryotic elongation factor 2 kinase: in silico, synthesis and in vitro studies","volume":"116","author":"Onder","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0565","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10549-018-4847-2","article-title":"Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer","volume":"171","author":"Kabil","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148014_bb0570","doi-asserted-by":"crossref","first-page":"11641","DOI":"10.18632\/oncotarget.14264","article-title":"MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase","volume":"8","author":"Bayraktar","year":"2017","journal-title":"Oncotarget"},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.148014_bb0575","doi-asserted-by":"crossref","first-page":"15837","DOI":"10.1021\/acs.jmedchem.4c01484","article-title":"Structure-activity relationship studies of substituted 2-phenyl-1,2,4-triazine-3,5(2H,4H)-dione analogues: development of potent eEF2K degraders against triple-negative breast cancer","volume":"67","author":"Zhao","year":"2024","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148014_bb0580","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41588-023-01507-7","article-title":"Molecular classification of hormone receptor-positive HER2-negative breast cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Nat. Genet."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.148014_bb0585","doi-asserted-by":"crossref","first-page":"18025","DOI":"10.1021\/acs.jmedchem.1c01382","article-title":"Discovery of novel dual-target inhibitor of bromodomain-containing protein 4\/casein kinase 2 inducing apoptosis and autophagy-associated cell death for triple-negative breast cancer therapy","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0590","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejmech.2017.12.046","article-title":"Design, synthesis, and biological evaluation of polo-like kinase 1\/eukaryotic elongation factor 2 kinase (PLK1\/EEF2K) dual inhibitors for regulating breast cancer cells apoptosis and autophagy","volume":"144","author":"Pan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148014_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104813","article-title":"Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor","volume":"299","author":"Piserchio","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0600","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1476-4598-12-171","article-title":"Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms","volume":"12","author":"Kumar","year":"2013","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148014_bb0605","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12402","article-title":"Fluoxetine induces autophagic cell death via eEF2K-AMPK-mTOR-ULK complex axis in triple negative breast cancer","volume":"51","author":"Sun","year":"2018","journal-title":"Cell Prolif."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0610","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11095-020-2774-5","article-title":"Delivery of small molecule EF2 kinase inhibitor for breast and pancreatic cancer cells using hyaluronic acid based nanogels","volume":"37","author":"Comert Onder","year":"2020","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148014_bb0615","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1021\/acsptsci.1c00030","article-title":"Target-driven design of a coumarinyl chalcone scaffold based novel EF2 kinase inhibitor suppresses breast cancer growth in vivo","volume":"4","author":"Comert Onder","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148014_bb0620","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/jnc.13407","article-title":"Eukaryotic elongation factor 2 kinase regulates the synthesis of microtubule-related proteins in neurons","volume":"136","author":"Kenney","year":"2016","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0625","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004026","article-title":"eEF2K promotes PD-L1 stabilization through inactivating GSK3\u03b2 in melanoma","volume":"10","author":"Chen","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148014_bb0630","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/cdd.2017.79","article-title":"MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation","volume":"24","author":"Delaidelli","year":"2017","journal-title":"Cell Death Differ."},{"issue":"29","key":"10.1016\/j.ijbiomac.2025.148014_bb0635","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.2147\/DDDT.S169952","article-title":"Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma","volume":"12","author":"Zhao","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148014_bb0640","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/jcmm.12361","article-title":"Elongation factor-2 kinase regulates TG2\/\u03b21 integrin\/Src\/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion","volume":"18","author":"Ashour","year":"2014","journal-title":"J. Cell. Mol. Med."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.148014_bb0645","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154886","article-title":"Discovery of new inhibitors of eEF2K from traditional Chinese medicine based on in silico screening and in vitro experimental validation","volume":"27","author":"Fu","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0650","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","article-title":"Role of P-glycoprotein in pharmacokinetics: clinical implications","volume":"42","author":"Lin","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148014_bb0655","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.bbrc.2017.12.132","article-title":"PAFR-deficiency alleviates myocardial ischemia\/reperfusion injury in mice via suppressing inflammation, oxidative stress and apoptosis","volume":"495","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.148014_bb0660","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1080\/14786419.2019.1596099","article-title":"New sorbicillinoid derivatives with GLP-1R and eEF2K affinities from a sponge-derived fungus Penicillium chrysogenum 581F1","volume":"34","author":"Cao","year":"2020","journal-title":"Nat. Prod. Res."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.148014_bb0665","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1158\/0008-5472.CAN-04-3141","article-title":"Farnesyltransferase inhibitor SCH66336 induces rapid phosphorylation of eukaryotic translation elongation factor 2 in head and neck squamous cell carcinoma cells","volume":"65","author":"Ren","year":"2005","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148014_bb0670","article-title":"Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinoma","volume":"129","author":"Xu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0675","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.3389\/fimmu.2018.03149","article-title":"Resveratrol-induced xenophagy promotes intracellular Bacteria clearance in intestinal epithelial cells and macrophages","volume":"9","author":"Al Azzaz","year":"2018","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.148014_bb0680","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1158\/1078-0432.CCR-17-1959","article-title":"Dual suppressive effect of miR-34a on the FOXM1\/eEF2-kinase axis regulates triple-negative breast cancer growth and invasion","volume":"24","author":"Bayraktar","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.148014_bb0685","doi-asserted-by":"crossref","first-page":"16619","DOI":"10.18632\/oncotarget.7672","article-title":"FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells","volume":"7","author":"Hamurcu","year":"2016","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.148014_bb0690","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16223823","article-title":"Therapeutic landscape of FOXM1 in triple-negative breast cancer and aggressive solid cancers","volume":"16","author":"Dilmac","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148014_bb0695","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400504","article-title":"Novel benzothiazole\/benzothiazole thiazolidine-2,4-dione derivatives as potential FOXM1 inhibitors: in silico, synthesis, and in vitro studies","volume":"357","author":"Abusharkh","year":"2024","journal-title":"Arch. Pharm."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.148014_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146792","article-title":"Inhibition of FOXM1 leads to suppression of cell proliferation, migration, and invasion through AXL\/eEF2 kinase signaling and induces apoptosis and ferroptosis in GBM cells","volume":"26","author":"Biltekin","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148014_bb0705","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.148014_bb0710","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2217\/nnm-2017-0081","article-title":"Modified gold-based siRNA nanotherapeutics for targeted therapy of triple-negative breast cancer","volume":"12","author":"Shahbazi","year":"2017","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0715","article-title":"Advances in nano drug delivery systems for enhanced efficacy of emodin in cancer therapy","volume":"9","author":"Ai","year":"2025","journal-title":"Int. J. Pharm. X"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0720","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tibtech.2018.08.002","article-title":"RNAi\/CRISPR screens: from a pool to a valid hit","volume":"37","author":"Schuster","year":"2019","journal-title":"Trends Biotechnol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148014_bb0725","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16121571","article-title":"Advances in research of hydrogel microneedle-based delivery systems for disease treatment","volume":"16","author":"Cao","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0730","article-title":"Trends of high-impact studies in pharmacology and pharmacy: a cross-sectional study","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148014_bb0735","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1159\/000495831","article-title":"Gastric adenocarcinoma predictive long intergenic non-coding RNA promotes tumor occurrence and progression in non-small cell lung cancer via regulation of the miR-661\/eEF2K signaling pathway","volume":"51","author":"Gu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.148014_bb0740","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.jmb.2019.05.019","article-title":"Solution structure of the carboxy-terminal tandem repeat domain of eukaryotic elongation factor 2 kinase and its role in substrate recognition","volume":"431","author":"Piserchio","year":"2019","journal-title":"J. Mol. Biol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148014_bb0745","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1128\/MCB.00388-14","article-title":"A conserved loop in the catalytic domain of eukaryotic elongation factor 2 kinase plays a key role in its substrate specificity","volume":"34","author":"Moore","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0750","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jep.2015.02.025","article-title":"Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma","volume":"164","author":"Wang","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148014_bb0755","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.2147\/OTT.S115309","article-title":"Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells","volume":"9","author":"Liu","year":"2016","journal-title":"Onco. Targets Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148014_bb0760","first-page":"295","article-title":"Calcium\/calmodulin-dependent protein kinases","volume":"5","author":"Nairn","year":"1994","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148014_bb0765","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12032-024-02427-0","article-title":"A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells","volume":"41","author":"Abusharkh","year":"2024","journal-title":"Med. Oncol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.148014_bb0770","doi-asserted-by":"crossref","first-page":"eadf7001","DOI":"10.1126\/sciadv.adf7001","article-title":"The autism susceptibility kinase, TAOK2, phosphorylates eEF2 and modulates translation","volume":"10","author":"Henis","year":"2024","journal-title":"Sci. Adv."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148014_bb0775","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1007\/s00204-024-03865-5","article-title":"Research advances on CaMKs-mediated neurodevelopmental injury","volume":"98","author":"Kong","year":"2024","journal-title":"Arch. Toxicol."},{"issue":"0","key":"10.1016\/j.ijbiomac.2025.148014_bb0780","article-title":"Eukaryotic elongation factor 2 kinase inhibitor, A484954 inhibits perivascular sympathetic nerve stimulation-induced vasoconstriction in isolated renal artery","volume":"926","author":"Tomoko","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148014_bb0785","article-title":"The alphavirus nonstructural protein 2 NTPase induces a host translational shut-off through phosphorylation of eEF2 via cAMP-PKA-eEF2K signaling","volume":"19","author":"Emmely E","year":"2023","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148014_bb0790","article-title":"mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia","volume":"37","author":"Natasha","year":"2023","journal-title":"Leukemia"},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.148014_bb0795","article-title":"ADP enhances the allosteric activation of eukaryotic elongation factor 2 kinase by calmodulin","volume":"120","author":"Andrea","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0800","article-title":"eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3\u03b2 and improving autophagy dysfunction","volume":"41","author":"Junjie","year":"2024","journal-title":"Cell Biol. Toxicol."},{"issue":"0","key":"10.1016\/j.ijbiomac.2025.148014_bb0805","article-title":"Main active components of Si-Miao-Yong-An decoction (SMYAD) attenuate autophagy and apoptosis via the PDE5A-AKT and TLR4-NOX4 pathways in isoproterenol (ISO)-induced heart failure models","volume":"176","author":"Minru","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148014_bb0810","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41392-023-01648-5","article-title":"Control of CD4(+) T cells to restrain inflammatory diseases via eukaryotic elongation factor 2 kinase","volume":"8","author":"Peng","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148014_bb0815","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41419-024-06891-4","article-title":"The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation","volume":"15","author":"Lim","year":"2024","journal-title":"Cell Death Dis."},{"issue":"0","key":"10.1016\/j.ijbiomac.2025.148014_bb0820","article-title":"Targeting eEF2K induces oxidative stress and sensitizes cancer cells to ferroptosis induction","volume":"1001","author":"Jianping","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148014_bb0825","article-title":"Eukaryotic elongation factor 2 kinase inhibitor, A484954 potentiates \u03b2-adrenergic receptor agonist-induced acute decrease in diastolic blood pressure in rats","volume":"81","author":"Tomoko","year":"2019","journal-title":"J. Vet. Med. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148014_bb2000","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114108","article-title":"Structural basis of selective TRPM7 inhibition by the anticancer agent CCT128930","volume":"43","author":"Nadezhdin","year":"2024","journal-title":"Cell Rep."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302508571X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302508571X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:42:06Z","timestamp":1781743326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302508571X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":166,"alternative-id":["S014181302508571X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148014","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unravelling the oncogenic role of eukaryotic elongation factor 2 kinase: A revisited review from underlying mechanisms to targeted therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"148014"}}